Form 4: Arteris Inc. CEO Charles Janac Sells 50,000 Shares
SEC Form 4
Arteris, Inc. CEO Charles Janac sold 50,000 shares of common stock on February 3, 2025, at a weighted average price of $10.3295 per share, pursuant to a pre-arranged 10b5-1 trading plan.
Summary
- On February 3, 2025, Charles Janac, the President and CEO of Arteris, Inc., sold 50,000 shares of the company's common stock.
- The sale was executed at a weighted average price of $10.3295 per share.
- The transactions occurred under a pre-arranged 10b5-1 trading plan adopted on February 27, 2024.
- Following the transaction, Janac directly owns 260,088 shares and indirectly owns 9,907,691 shares through Bayview Legacy, LLC, and 63,252 shares through the Charles and Lydia Janac Trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-existing trading plan. It doesn't inherently indicate positive or negative prospects for the company.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information.
Stakeholder Impact
- The sale of shares by the CEO could be perceived negatively by some shareholders, although the use of a 10b5-1 plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date the 10b5-1 trading plan was adopted by the Reporting Person |
| 02/03/2025 | Date of the transaction (stock sale) |
| 02/05/2025 | Date of the signature on the Form 4 filing |
Keywords
Arteris, Inc., Charles Janac, Stock Sale, Form 4, Insider Trading, 10b5-1 Trading Plan, AIP, Bayview Legacy, LLC, Charles and Lydia Janac Trust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.